New nanoparticles can perform gene editing in the lungs, MIT News

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems - Computational and Structural Biotechnology Journal

Nanoparticles target lung disease

Inhaled Carrier May Work for CF mRNA Therapy, Mouse Study Finds

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

Nanoparticles may correct genetic defects in cystic fibrosis lungs

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

IJMS, Free Full-Text

Revolutionary nanoparticles enable gene-editing in lungs

MIT scientists develop new nanoparticles to improve vaccine delivery